| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |